Log on / register
Feedback | Support | My details

Email this article to a friend

Randomized phase II – study evaluating EGFR targeting therapy with Cetuximab in combination with radiotherapy and chemotherapy for patients with locally advanced pancreatic cancer – PARC: study protocol [ISRCTN56652283]

R Krempien* email, MW Muenter* email, PE Huber email, S Nill email, H Friess email, C Timke email, B Didinger email, P Buechler email, S Heeger email, KK Herfarth email, A Abdollahi email, MW Buchler email and J Debus email

BMC Cancer 2005, 5:131doi:10.1186/1471-2407-5-131

Your name*
Your email address*
Recipient's email address*
(multiple email addresses should be separated with commas)
Email format
Please type your message into the box below:
Terms and Conditions Privacy statement Information for advertisers Jobs at BMC Contact us
© 1999-2010 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.